Documents & Downloads

Zotresiran

Xanthine dehydrogenase synthesis reducer

Zotresiran is a small interfering RNA (siRNA) designed to reduce the synthesis of xanthine dehydrogenase, an enzyme involved in purine metabolism. By downregulating this target, Zotresiran can modulate uric acid levels, making it valuable for research in conditions such as gout and hyperuricemia. Its application in gene silencing offers researchers a powerful tool for investigating metabolic disorders and developing therapeutic strategies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2756821-85-7
Applications	Xanthine dehydrogenase synthesis reducer

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.